Division of Cardiology, Heart Center, Konyang University Hospital, Daejeon, Korea.
Korean Circ J. 2015 Jan;45(1):28-37. doi: 10.4070/kcj.2015.45.1.28. Epub 2015 Jan 26.
Both carotid intima-media thickness (CIMT) and carotid plaque are important factors in the primary prevention of cardiac disease. However, it is unclear which one is more important for prognosis, especially in patients with coronary artery disease (CAD).
In total, 1426 consecutive CAD patients, proven by angiography, were followed-up for a mean of 85 months. The study population was divided into four groups depending on the CIMT (≥0.83 mm, >95 percentile in Korea) and the presence or absence of carotid plaque.
Patients with carotid plaque and thick CIMT (n=237, 16.6%) had a higher prevalence of hypertension, diabetes mellitus, and dyslipidemia than those had plaque and thin CIMT (n=213, 14.9%), those without plaque and thick CIMT (n=265, 18.6%) and those without plaque and thin CIMT (n=711, 49.9%). The patients with carotid plaque and thick CIMT group had a higher cardiac mortality rate (20.7% vs. 13.1%, 9.4% and 3.9%, respectively, p<0.001) and higher major adverse cardiovascular events (MACE) including death, acute myocardial infarction, and stroke (27.8% vs. 18.8%, 15.5% and 9.3%, respectively, p<0.001) than any other groups. Multivariate Cox regression analysis showed that the presence of carotid plaque with thick CIMT had the highest hazard ratio (HR) compared to other groups (HR 2.23 vs. 1.81, 2.01) for cardiac mortality. Also, carotid plaque had a higher HR than CIMT for mortality (HR 1.56 vs. 1.37) and MACE (HR 1.54 vs. 1.36) in the total study population.
Carotid plaque is a more important prognostic factor than CIMT in patients with CAD, and adding a thick CIMT to carotid plaque increases the prognostic power for cardiac events.
颈动脉内膜中层厚度(CIMT)和颈动脉斑块都是心脏病一级预防的重要因素。然而,对于预后,尚不清楚哪个因素更为重要,特别是在冠心病(CAD)患者中。
本研究共纳入了 1426 例经血管造影证实的 CAD 患者,平均随访 85 个月。根据 CIMT(≥0.83mm,韩国第 95 百分位数)和颈动脉斑块的有无,将研究人群分为四组。
颈动脉斑块且 CIMT 增厚(n=237,16.6%)的患者高血压、糖尿病和血脂异常的患病率高于颈动脉斑块且 CIMT 正常(n=213,14.9%)、无斑块且 CIMT 增厚(n=265,18.6%)和无斑块且 CIMT 正常(n=711,49.9%)的患者。颈动脉斑块且 CIMT 增厚组的心脏死亡率(20.7% vs. 13.1%、9.4%和 3.9%,p<0.001)和主要不良心血管事件(MACE)发生率(死亡、急性心肌梗死和卒中)(27.8% vs. 18.8%、15.5%和 9.3%,p<0.001)均高于其他组。多变量 Cox 回归分析显示,与其他组相比,颈动脉斑块且 CIMT 增厚组的心脏死亡风险最高(HR 2.23 vs. 1.81、2.01)。在整个研究人群中,颈动脉斑块的死亡风险(HR 1.56 vs. 1.37)和 MACE 风险(HR 1.54 vs. 1.36)均高于 CIMT。
在 CAD 患者中,颈动脉斑块是比 CIMT 更为重要的预后因素,而 CIMT 增厚与颈动脉斑块联合则可提高心脏事件的预测能力。